We are live on
!
Find out more
BA
BlackRock Advisors Portfolio holdings
AUM
$98.8B
1-Year Est. Return
15.8%
This Fund
S&P 500
This Quarter
Est. Return
-7.26%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.35%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$93.3B
AUM Growth
-$2.89B
(-3%)
Cap. Flow
+$5.74B
Cap. Flow
% of AUM
6.15%
Top 10 Holdings %
Top 10 Hldgs %
15.28%
Holding
3,878
New
163
Increased
1,568
Reduced
1,679
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$423M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$367M |
| 3 |
ExxonMobil
XOM
|
+$337M |
| 4 |
Johnson & Johnson
JNJ
|
+$257M |
| 5 |
Biogen
BIIB
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$195M |
| 2 |
AbbVie
ABBV
|
+$188M |
| 3 |
JPMorgan Chase
JPM
|
+$183M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$176M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.49% |
| 2 | Financials | 16.75% |
| 3 | Technology | 9.99% |
| 4 | Industrials | 8.32% |
| 5 | Energy | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVF
1676
Eaton Vance Senior Income Trust
EVF
$89.9M
| $999K | ﹤0.01% |
170,246
| – | – |
|
|
MORE
1677
DELISTED
Monogram Residential Trust, Inc.
MORE
| $998K | ﹤0.01% |
107,173
-1,818
| -2% | -$17K |
|
|
DVAX
1678
DELISTED
Dynavax Technologies
DVAX
| $996K | ﹤0.01% |
40,582
+20,532
| +102% | +$581K |
|
|
PACW
1679
DELISTED
PacWest Bancorp
PACW
| $996K | ﹤0.01% |
23,263
+8,881
| +62% | +$398K |
|
1680
Delek US
DK
$3.85B
| $995K | ﹤0.01% |
35,921
-63,670
| -64% | -$2.14M |
|
1681
Unifirst Corp
UNF
$5.43B
| $995K | ﹤0.01% |
9,312
-499
| -5% | -$55.6K |
|
|
FCE.A
1682
DELISTED
Forest City Realty Trust, Inc.
FCE.A
| $993K | ﹤0.01% |
49,311
+24,511
| +99% | +$540K |
|
1683
Kemper
KMPR
$1.82B
| $992K | ﹤0.01% |
28,040
-1,274
| -4% | -$47.4K |
|
|
MDP
1684
DELISTED
Meredith Corporation
MDP
| $991K | ﹤0.01% |
23,274
-755
| -3% | -$36K |
|
1685
Dine Brands
DIN
$458M
| $989K | ﹤0.01% |
10,787
-352
| -3% | -$34.4K |
|
1686
Hexcel
HXL
$8.3B
| $986K | ﹤0.01% |
21,971
+7,724
| +54% | +$381K |
|
1687
Commercial Metals
CMC
$7.8B
| $985K | ﹤0.01% |
72,689
-211,322
| -74% | -$3.23M |
|
1688
IMAX
IMAX
$2.59B
| $985K | ﹤0.01% |
29,145
-1,239
| -4% | -$42.9K |
|
1689
Align Technology
ALGN
$12.6B
| $983K | ﹤0.01% |
17,321
-98,830
| -85% | -$5.89M |
|
|
CSG
1690
DELISTED
CHAMBERS STR PPTYS COM
CSG
| $983K | ﹤0.01% |
151,423
-5,701
| -4% | -$40.7K |
|
|
DF
1691
DELISTED
Dean Foods Company
DF
| $981K | ﹤0.01% |
59,358
-2,554
| -4% | -$43.6K |
|
1692
Jabil
JBL
$31.7B
| $979K | ﹤0.01% |
43,772
+15,101
| +53% | +$300K |
|
|
EVV
1693
Eaton Vance Limited Duration Income Fund
EVV
$1.06B
| $977K | ﹤0.01% |
77,083
| – | – |
|
|
SCS
1694
DELISTED
Steelcase
SCS
| $977K | ﹤0.01% |
53,091
-1,600
| -3% | -$28.7K |
|
1695
Trustmark
TRMK
$2.74B
| $977K | ﹤0.01% |
42,186
-1,613
| -4% | -$38.2K |
|
|
OVTI
1696
DELISTED
OMNIVISION TECHNOLOGIES INC
OVTI
| $970K | ﹤0.01% |
36,922
-1,166
| -3% | -$29K |
|
1697
Lamar Advertising Co
LAMR
$16.5B
| $965K | ﹤0.01% |
18,488
+6,618
| +56% | +$370K |
|
1698
Sabra Healthcare REIT
SBRA
$5.61B
| $964K | ﹤0.01% |
41,604
+3,020
| +8% | +$77.1K |
|
1699
Old Dominion Freight Line
ODFL
$47.1B
| $963K | ﹤0.01% |
47,340
+17,046
| +56% | +$387K |
|
|
BLT
1700
DELISTED
BLOUNT INTERNATIONAL (NEW)
BLT
| $962K | ﹤0.01% |
172,755
-449,020
| -72% | -$3.31M |
|
Similar funds
BIM
BJ
IC
EAM
MFS
CIM
KAM
PFM
BlackRock Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, BlackRock Advisors held 3,878 positions worth $93.3B, down 3% from $96.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock Advisors deployed $5.74B of net new capital in Q3 2015, opening 163 new positions and adding to 1,568 existing holdings. Its largest new stake was Allergan plc: 186,940 shares worth $176M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $195M trimmed.
- BlackRock Advisors's largest Q3 2015 buy was Allergan plc: 186,940 shares worth $176M.
- BlackRock Advisors added most to Apple in Q3 2015, an estimated $423M increase.
- BlackRock Advisors's biggest Q3 2015 reduction was Vertex Pharmaceuticals, cutting an estimated $195M.
- BlackRock Advisors fully exited RECEPTOS INC COM STK (DE) in Q3 2015, selling an estimated $108M.
- BlackRock Advisors's ten largest holdings make up 15% of its $93.3B portfolio in Q3 2015.
- BlackRock Advisors opened 163 new positions and closed 111 in Q3 2015.
- BlackRock Advisors's portfolio value fell 3% quarter-over-quarter to $93.3B.
Based on BlackRock Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.